Skip to content
Dose Brief
Menu
The shortlist

Alternatives to SkinnyRx

SkinnyRx sits at No. 319 in our ranking with a Brief Score of 58. Here are the GLP-1 desks we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs SkinnyRx.

Our top alternative

No. 1 here

CoreAge Rx

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Sema
$99/mo
Tirz
$149/mo
Coverage
All 50 states

More desks worth weighing

No. 27 · Grade B

TeleCareSpot

85/100

A nationwide desk with an oral option — full-formulary, but priced at the premium end.

Sema
$299/mo
Coverage
All 50 states
price stable
No. 183 · Grade C

AquaVita NextGen

67/100

AquaVita NextGen (AquaVita Wellness & Medspa) offers compounded semaglutide and tirzepatide (ODT tablets).

Sema
From $375/mo (first-month rate, compounded)
Coverage
5 states
new to the tracker, no prior reading
No. 165 · Grade C

Dr. Arevitalize

68/100

Dr. Arevitalize (Dr.Arevitalize Health, Inc.) is a LegitScript-certified telehealth platform offering compounded GLP-1 weight-loss medication in both injectable and oral-capsule forms — semaglutide fr

Sema
From $319/mo (compounded)
Coverage
Coverage not published
new to the tracker, no prior reading
No. 43 · Grade B−

Apex MD

80/100

Apex MD is a US virtual telemedicine platform licensed in all 50 states that prescribes compounded GLP-1 medications for weight loss.

Sema
$299/mo
Coverage
All 50 states
new to the tracker, no prior reading
No. 128 · Grade C

MyStart Health

71/100

MyStart Health offers all-inclusive compounded semaglutide and tirzepatide at $299/month with a price-lock guarantee, same-day physician consultations, and 24/7 care team access.

Sema
From $299/mo (all doses, compounded)
Coverage
Coverage not published
new to the tracker, no prior reading

FDA warning letter, September 2025 — issued to Matthew Stern, CEO MyStart Health LLC.. See the FDA's warning letter database.

No. 149 · Grade C

Claya

69/100

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Sema
From $299/mo (compounded)
Coverage
Coverage not published
new to the tracker, no prior reading
No. 102 · Grade C

NovoCare Pharmacy

73/100

Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide).

Sema
From $349/mo (2.4 mg dose, brand-name)
Coverage
All 50 states
new to the tracker, no prior reading
No. 216 · Grade C

Willow

66/100

Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

Sema
From $299/mo (starting dose, compounded)
Coverage
Coverage not published
new to the tracker, no prior reading

On the record

The FDA issued a warning letter to Lean Rx, Inc. dba SkinnyRx in February 2026. SkinnyRx keeps its place here and its link is unchanged — but you should know the letter exists before you start care. Read it in the FDA's warning letter database.

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.